The IPC Psoriasis Masterclass is designed for dermatologists who are making treatment decisions and managing patients with psoriasis and are interested in specializing in psoriasis.
Over the five days of the course, IPC’s world-renowned experts will cover a variety of topics including the pathogenesis of psoriasis, new and emerging therapies and how to be an advocate for your patient.
The Masterclass agenda has been carefully developed to provide knowledge for daily use to the practicing dermatologist in an intimate environment designed to maximize faculty/participant interactions. Through lectures, panels, case-based discussions and question-answer sessions, attendees will obtain practical and important information for their dermatology practice.
The IPC Masterclass is open to dermatologists and general practitioners who meet the following criteria:
There is no cost to attend the program, but space is limited. The application deadline is May 22, 2023.
Timezones:
Tijuana: 11:00 – 1:00 pm (UTC -7)
Mexico City / Guatemala City / Juarez: 12:00 – 2:00 pm (UTC -6)
Bogota / Lima / Panama: 1:00 – 3:00 pm (UTC -5)
Santiago / Asunción / Santiago de los Caballeros: 2:00 – 4:00 pm (UTC -4)
Buenos Aires / São Paulo: 3:00 – 5:00 pm (UTC -3)
WELCOME + INTRODUCTION
Claudia de la Cruz
Clinical Manifestations of Psoriasis
Peter van de Kerkhof
Recategorization of Psoriasis Severity
Bruce Strober
Global Psoriasis Atlas
Darren Ashcroft
Patient Perspectives
Claudia de la Cruz
Clinical Cases
CLOSING COMMENTS
André Carvalho
WELCOME + INTRODUCTION
André Carvalho
Updates in Pathophysiology & Genetics
Matías Maskin
Psoriasis in Special Areas
Daniela Armijo
Updates on Comorbidities
Benjamin Hidalgo
Updates on Psoriatic Arthritis
Arthur Kavanaugh
Clinical Cases
CLOSING COMMENTS
Daniela Armijo
WELCOME + INTRODUCTION
Daniela Armijo
Generalized Pustular Psoriasis
Renata Magalhaes
Topical Therapies and Phototherapy
Fernando Valenzuela
Target to Treat & Methotrexate
André Carvalho
Biosimilars
Arnon Cohen
Clinical Cases
CLOSING COMMENTS
Claudia de la Cruz
WELCOME + INTRODUCTION
Claudia de la Cruz
Pediatric Psoriasis
Amy Paller
Anti TNF-a
César Gonzalez
Anti IL 17, Anti IL12/23 and Anti IL-23
Paolo Gisondi
New Oral Therapies
Andrew Pink
Clinical Cases
CLOSING COMMENTS
André Carvalho
WELCOME + INTRODUCTION
André Carvalho
Screening and Monitorization of Biologics
Tiago Torres
Personalized Treatment
Ron Vender
Biomarkers in Psoriasis
Jason Hawkes
My Challenging Cases
Wayne Gulliver
Clinical Cases
CLOSING COMMENTS
Claudia de la Cruz, André Carvalho, and Daniela Armijo
Cookie | Duration | Description |
---|---|---|
cookielawinfo-checkbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
cookielawinfo-checkbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
cookielawinfo-checkbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |